ERBB2 and breast carcinoma: Kim et al. [8] reported that breast cancer subtypes consisted of 48.1% luminal (HER2-negative), 22.2% hormone receptor (HR)-negative and HER2-positive, 22.2% HR-positive and HER2-positive, and 7.4% triple-negative (ER/PR/HER2).